Thursday, September 30th 12:00 p.m. EDT.
As a result of participating in this activity, learners will be able to: Identify novel targets in B and T-cell lymphomas, discuss the advances in targeted therapies for lymphomas, review recent advances in the immunobiology of lymphomas, and identify advances in immune-based therapies for lymphomas
The target audience for this presentation: Medical oncologists and hematologists/ Immunologists
USF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
USF Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
USF Health (provider number 2970) is an approved provider of continuing education for nurses through Florida Board of Nursing. This activity has been approved for 1.0 contact hours.
View related document for accreditation information.
Relevant Financial Relationships
Prior to the activity, USF Health will disclose and mitigate all relevant financial relationships that relate to the content of the activity.
If you have any questions or credit related inquiries, please contact USF Health at firstname.lastname@example.org
Director, TGH Cancer Institute
Professor, Department of Medical Engineering, College of Engineering, USF